{"count":6,"index":{"built_at":"2026-07-27T20:57:25.953253+00:00","public_records":55311,"revision":"a8e3318e1de81eabc44457bb"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: CYP2D6 in the context of longevity"},"results":[{"answer":"The provided context does not contain any direct evidence linking CYP2D6 to longevity. CYP2D6 is a well-known drug-metabolizing enzyme, and some research has explored its variants in relation to age-related diseases or response to supplements, but the evidence is weak and inconsistent. The context covers topics like APOE, FUT2, microbiome, and diet, but not CYP2D6. Therefore, any claim about CYP2D6 and longevity is not supported by the given information. Users should be cautious: consumer genetic tests often report CYP2D6 variants for medication guidance, but their role in extending lifespan is speculative at best. A conservative assessment rates the evidence as unclear. For personalized advice, consult a healthcare professional familiar with pharmacogenetics.","area":"gesundheit","canonical_id":"gesundheit:canonical-0c8e2ad861c70ee8f7bd29d5","id":"public-ea13617187b17ea8b930555b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2D6 in the context of longevity","score":23.48413006,"snippet":"The provided context does not contain any direct evidence linking CYP2D6 to longevity. CYP2D6 is a well-known drug-metabolizing enzyme, and some research has explored its variants in relation to age-related diseases or response to supplements, but the evidence is weak and inconsistent. The context covers topics like APOE, FUT2, microbiome, and diet, but not CYP2D6. Therefore, any claim about CYP2D6 and longevity is not supported by the given information. Users should be cautious: consumer genetic tests often report CYP2D6 variants for medication guidance, but their role in extending lifespan is speculative at best. A conservative assessment rates the evidence as unclear. For personalized adv","sources":[],"title":"Evidence check: CYP2D6 in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-ea13617187b17ea8b930555b/evidence-check-cyp2d6-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP2D6 is a key phase I drug-metabolizing enzyme involved in the breakdown of many medications and endogenous compounds like neurotransmitters. In the context of longevity, CYP2D6 is sometimes discussed regarding its role in metabolizing substances such as melatonin and serotonin, which can influence sleep, mood, and oxidative stress. However, the evidence for a direct link between specific CYP2D6 variants and extended lifespan is weak. Most studies are pharmacogenetic, focusing on drug response rather than longevity. Moreover, the effect of single CYP2D6 SNPs on enzyme activity is heavily influenced by copy number variations and other factors. Consumer DNA tests like those from MyBody-X can detect these variants, but their clinical relevance for lifespan prediction is unclear. No validated biomarkers exist that allow longevity prediction from CYP2D6 data. The evidence is therefore mechanistic/insufficient. Consumers should not base life-extension decisions on such single-gene analyses.","area":"gesundheit","canonical_id":"gesundheit:canonical-8bfae267341e910a54b5f6a4","id":"public-415129974f1613fba704cb30","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2D6 in the context of Langlebigkeit","score":22.98257806,"snippet":"CYP2D6 is a key phase I drug-metabolizing enzyme involved in the breakdown of many medications and endogenous compounds like neurotransmitters. In the context of longevity, CYP2D6 is sometimes discussed regarding its role in metabolizing substances such as melatonin and serotonin, which can influence sleep, mood, and oxidative stress. However, the evidence for a direct link between specific CYP2D6 variants and extended lifespan is weak. Most studies are pharmacogenetic, focusing on drug response rather than longevity. Moreover, the effect of single CYP2D6 SNPs on enzyme activity is heavily influenced by copy number variations and other factors. Consumer DNA tests like those from MyBody-X can","sources":[],"title":"Evidence check: CYP2D6 in the context of Langlebigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-415129974f1613fba704cb30/evidence-check-cyp2d6-in-the-context-of-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Pharmacogenetics Medicheck analyzes genetic variants affecting drug metabolism (e.g., CYP2D6, CYP2C19, SLCO1B1). In the context of longevity, direct evidence is weak: no randomized trials show that such a test extends lifespan. However, pharmacogenetics can help older adults avoid adverse drug reactions – an indirect benefit for healthspan. Evidence for the clinical validity of tested SNPs is moderate (human studies, but often small effect sizes). Important: This test does not replace medical advice; dose adjustments should only be made by qualified professionals. Moreover, many drug-gene interactions are not yet sufficiently proven. For an evidence-based longevity strategy, lifestyle factors (diet, exercise, sleep) are far more relevant than a single genetic test.","area":"gesundheit","canonical_id":"gesundheit:canonical-32a4ac98998ce54901abfda8","id":"public-e19b75e775649db7cf3734d9","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of longevity","score":21.57964129,"snippet":"The Pharmacogenetics Medicheck analyzes genetic variants affecting drug metabolism (e.g., CYP2D6, CYP2C19, SLCO1B1). In the context of longevity, direct evidence is weak: no randomized trials show that such a test extends lifespan. However, pharmacogenetics can help older adults avoid adverse drug reactions – an indirect benefit for healthspan. Evidence for the clinical validity of tested SNPs is moderate (human studies, but often small effect sizes). Important: This test does not replace medical advice; dose adjustments should only be made by qualified professionals. Moreover, many drug-gene interactions are not yet sufficiently proven. For an evidence-based longevity strategy, lifestyle fa","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e19b75e775649db7cf3734d9/evidence-check-pharmakogenetik-medicheck-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Pharmakogenetik Medicheck from MyBody-X is marketed in the context of longevity, but the evidence for this use is weak. Pharmacogenetics examines how genetic variants (e.g., in CYP2C19, CYP2D6) affect drug metabolism – clinically useful for dose adjustment, but not for predicting lifespan. Longevity is multifactorial: diet, exercise, environment, and chance play far larger roles than single drug-metabolism genes. The test provides no personalized longevity recommendations, only risk indications for drug metabolism. Moreover, in Germany it falls under the Genetic Diagnostics Act (GenDG) and is labeled as a lifestyle test, not medical diagnostics. Its relevance for 'longevity' is therefore misleading. Those aiming to optimize lifespan should rely on validated biomarkers (blood values, microbiome) and evidence-based lifestyle interventions – not a pharmacogenetic test.","area":"gesundheit","canonical_id":"gesundheit:canonical-7a4039b5b03ca11245bdf913","id":"public-653e44f084c7acccd2c98b2c","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of Langlebigkeit","score":21.29783022,"snippet":"The Pharmakogenetik Medicheck from MyBody-X is marketed in the context of longevity, but the evidence for this use is weak. Pharmacogenetics examines how genetic variants (e.g., in CYP2C19, CYP2D6) affect drug metabolism – clinically useful for dose adjustment, but not for predicting lifespan. Longevity is multifactorial: diet, exercise, environment, and chance play far larger roles than single drug-metabolism genes. The test provides no personalized longevity recommendations, only risk indications for drug metabolism. Moreover, in Germany it falls under the Genetic Diagnostics Act (GenDG) and is labeled as a lifestyle test, not medical diagnostics. Its relevance for 'longevity' is therefore","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of Langlebigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-653e44f084c7acccd2c98b2c/evidence-check-pharmakogenetik-medicheck-in-the-context-of-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, family history) alongside menopausal status. Without integration into a clinical framework, the test's value remains limited. Safety note: Do not rely solely on a consumer genetic test for cardiovascular risk assessment during menopause; consult a healthcare provider.","area":"gesundheit","canonical_id":"gesundheit:canonical-ccbfaab7adb4f3d36ade19ed","id":"public-c55149e2ad24f5be7e24dcab","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check in the context of menopause","score":20.38242146,"snippet":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, fam","sources":[],"title":"Evidence check: Cardio Risk Check in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c55149e2ad24f5be7e24dcab/evidence-check-cardio-risk-check-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The question about the cost of a large blood panel (großes Blutbild) at a doctor and common causes for ordering it is not addressed in the provided context. The context exclusively covers DNA tests (e.g., CYP2D6, FOXO3) and their limitations. Generally, costs vary by country and insurance: in Germany, statutory health insurance covers it if medically indicated; private costs range from €20–50. Common causes include routine check-ups, suspected deficiencies (iron, vitamins), infections, or chronic diseases. Since the context lacks relevant data, the evidence is rated 'unclear'. Caveat: MyBody-X is a nutrition/longevity DNA test, not a substitute for medical blood work.","area":"gesundheit","canonical_id":"gesundheit:canonical-89536e0dc5daa61c8d0ee4f9","id":"public-8039e58fd05deedab1e57826","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"was kostet ein großes blutbild beim arzt — what are common causes?","score":19.38859108,"snippet":"The question about the cost of a large blood panel (großes Blutbild) at a doctor and common causes for ordering it is not addressed in the provided context. The context exclusively covers DNA tests (e.g., CYP2D6, FOXO3) and their limitations. Generally, costs vary by country and insurance: in Germany, statutory health insurance covers it if medically indicated; private costs range from €20–50. Common causes include routine check-ups, suspected deficiencies (iron, vitamins), infections, or chronic diseases. Since the context lacks relevant data, the evidence is rated 'unclear'. Caveat: MyBody-X is a nutrition/longevity DNA test, not a substitute for medical blood work.","sources":[],"title":"was kostet ein großes blutbild beim arzt — what are common causes?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-8039e58fd05deedab1e57826/was-kostet-ein-grosses-blutbild-beim-arzt-what-are-common-causes/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}